Nigel D. L. Savage

Leiden University

Papers

1

Total Citations

126

H-Index

1

About

Nigel D. L. Savage is a leading researcher in tuberculosis drug discovery, with a primary focus on high-throughput screening and whole-cell assays to combat Mycobacterium tuberculosis. His most impactful contribution is the development of a pioneering high-throughput screen for tuberculosis progression, published in 2011 and cited over 126 times. This work addressed a critical bottleneck in the field: the lack of robust, whole-organism screening systems capable of identifying compounds that target the pathogen in its physiologically relevant state. By enabling the rapid evaluation of drug candidates against actively replicating and persistent mycobacteria, Savage’s assay has accelerated the search for novel therapeutics, particularly in the face of rising multi-drug resistant strains. His research has provided a vital tool for preclinical drug development, bridging the gap between in vitro activity and in vivo efficacy. Beyond this landmark paper, Savage’s work continues to influence tuberculosis research, emphasizing the need for innovative screening strategies to combat one of the world’s most persistent infectious diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
126
Total Citations
126
Avg Citations/Paper
🏆 Most Cited Paper
A High-Throughput Screen for Tuberculosis Progression
126 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Leiden University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago